These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22674574)

  • 1. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
    Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
    J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
    Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
    Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
    Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL/SnoN in TGF-β Signaling Pathway.
    Laigle V; Dingli F; Amhaz S; Perron T; Chouchène M; Colasse S; Petit I; Poullet P; Loew D; Prunier C; Levy L
    Mol Cell Proteomics; 2021; 20():100173. PubMed ID: 34740826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
    Stroschein SL; Wang W; Zhou S; Zhou Q; Luo K
    Science; 1999 Oct; 286(5440):771-4. PubMed ID: 10531062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SnoN Stabilizes the SMAD3/SMAD4 Protein Complex.
    Walldén K; Nyman T; Hällberg BM
    Sci Rep; 2017 Apr; 7():46370. PubMed ID: 28397834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
    Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
    J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Ski and SnoN Involved in the Tumorigenesis of Oral Squamous Cell Carcinoma Through Smad4?
    Alaeddini M; Etemad-Moghadam S
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):626-630. PubMed ID: 29734252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
    Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
    Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R; Zhang X; Yang J; Li Y; Liu Y
    J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
    Sarker KP; Wilson SM; Bonni S
    J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis.
    Chi C; Liang X; Cui T; Gao X; Liu R; Yin C
    Biomol Biomed; 2023 Nov; 23(6):1014-1025. PubMed ID: 37389959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
    Luo DD; Phillips A; Fraser D
    Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.